Supportive and Palliative Care for Patients with Oral Cancer

  • Pedro Diz DiosEmail author
  • Márcio Diniz Freitas
Part of the Textbooks in Contemporary Dentistry book series (TECD)


Oral cancer is a complex and persistent disease due to its recurrent nature and the sequela resulting from its treatment. The implementation of supportive measures is gaining special importance in patients living with cancer. The approach for the management, and supportive and palliative care should be multidisciplinary, involving practitioners from diverse specialties such as maxillofacial surgery, oral medicine, special care dentistry and restorative dentistry, oncology, radiation therapy, palliative care, nutrition, speech therapy, and physical therapy. Dentists can also play a relevant role in this team, from the diagnosis of the tumor to the completion of the rehabilitation process and subsequent follow-up. The palliative care planning for patients with oral cancer should follow a holistic approach, in which the physical and functional complications cannot be separated from their psychological implications, such as depression and guilt, or from the impact of the entire process on quality of life.


  1. 1.
    National Consensus Project for Quality Palliative Care Task Force. The clinical practice guideline for quality palliative care. 3rd ed. Pittsburgh: National Consensus Project for Quality Palliative Care; 2013.Google Scholar
  2. 2.
    Diz Dios P, Seoane Lestón J. Oral cancer pain. Oral Oncol. 2010;46(6):448–51.CrossRefGoogle Scholar
  3. 3.
    Saunders DP, Epstein JB, Elad S, Allemano J, Bossi P, van de Wetering MD, Rao NG, Potting C, Cheng KK, Freidank A, Brennan MT, Bowen J, Dennis K, Lalla RV, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21(11):3191–207.CrossRefGoogle Scholar
  4. 4.
    Shah JP, Gil Z. Current concepts in management of oral cancer--surgery. Oral Oncol. 2009;45(4–5):394–401.CrossRefGoogle Scholar
  5. 5.
    Diz Dios P, Fernández Feijoo J, Castro Ferreiro M, Alvarez Alvarez J. Functional consequences of partial glossectomy. J Oral Maxillofac Surg. 1994;52(1):12–4.CrossRefGoogle Scholar
  6. 6.
    Siddall KZ, Rogers SN, Butterworth CJ. The prosthodontic pathway of the oral cancer patient. Dent Update. 2012;39(2):98–100, 103–6.CrossRefGoogle Scholar
  7. 7.
    Sonis ST. Oral mucositis. Anticancer Drugs. 2011;22(7):607–12.CrossRefGoogle Scholar
  8. 8.
    Jensen SB, Jarvis V, Zadik Y, Barasch A, Ariyawardana A, Hovan A, Yarom N, Lalla RV, Bowen J, Elad S, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Systematic review of miscellaneous agents for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21(11):3223–32.CrossRefGoogle Scholar
  9. 9.
    Villa A, Sonis ST. Pharmacotherapy for the management of cancer regimen-related oral mucositis. Expert Opin Pharmacother. 2016;17(13):1801–7.CrossRefGoogle Scholar
  10. 10.
    Vissink A, van Luijk P, Langendijk JA, Coppes RP. Current ideas to reduce or salvage radiation damage to salivary glands. Oral Dis. 2015;21(1):e1–10.CrossRefGoogle Scholar
  11. 11.
    Riley P, Glenny AM, Hua F, Worthington HV. Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy. Cochrane Database Syst Rev. 2017;7:CD012744.PubMedGoogle Scholar
  12. 12.
    Kamstra JI, van Leeuwen M, Roodenburg JLN, Dijkstra PU. Exercise therapy for trismus secondary to head and neck cancer: a systematic review. Head Neck. 2017;39(11):2352–62.CrossRefGoogle Scholar
  13. 13.
    Owosho AA, Tsai CJ, Lee RS, Freymiller H, Kadempour A, Varthis S, Sax AZ, Rosen EB, Yom SK, Randazzo J, Drill E, Riedel E, Patel S, Lee NY, Huryn JM, Estilo CL. The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): the Memorial Sloan Kettering Cancer Center experience. Oral Oncol. 2017;64:44–51.CrossRefGoogle Scholar
  14. 14.
    Sultan A, Hanna GJ, Margalit DN, Chau N, Goguen LA, Marty FM, Rabinowits G, Schoenfeld JD, Sonis ST, Thomas T, Tishler RB, Treister NS, Villa A, Woo SB, Haddad R, Mawardi H. The use of hyperbaric oxygen for the prevention and management of osteoradionecrosis of the jaw: a Dana-Farber/Brigham and Women’s Cancer Center multidisciplinary guideline. Oncologist. 2017;22(3):343–50.CrossRefGoogle Scholar
  15. 15.
    De Felice F, de Vincentiis M, Luzzi V, Magliulo G, Tombolini M, Ruoppolo G, Polimeni A. Late radiation-associated dysphagia in head and neck cancer patients: evidence, research and management. Oral Oncol. 2018;77:125–30.CrossRefGoogle Scholar
  16. 16.
    Valdez JA, Brennan MT. Impact of oral cancer on quality of life. Dent Clin N Am. 2018;62(1):143–54.CrossRefGoogle Scholar
  17. 17.
    Rogers SN, Ahiaku S, Lowe D. Is routine holistic assessment with a prompt list feasible during consultations after treatment for oral cancer? Br J Oral Maxillofac Surg. 2018;56(1):24–8.CrossRefGoogle Scholar
  18. 18.
    Sharp L, Redfearn D, Timmons A, Balfe M, Patterson J. Post-traumatic growth in head and neck cancer survivors: is it possible and what are the correlates? Psychooncology. 2018;27:1517.CrossRefGoogle Scholar
  19. 19.
    Mitsudo K, Koizumi T, Iida M, Iwai T, Nakashima H, Oguri S, Kioi M, Hirota M, Koike I, Hata M, Tohnai I. Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for stage III and IV oral cancer: analysis of therapeutic results in 112 cases. Radiother Oncol. 2014;111(2):306–10.CrossRefGoogle Scholar

Further Reading

  1. Cocks H, Ah-See K, Capel M, Taylor P. Palliative and supportive care in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016;130(Suppl 2):S198–207.CrossRefGoogle Scholar
  2. Epstein JB, Güneri P, Barasch A. Appropriate and necessary oral care for people with cancer: guidance to obtain the right oral and dental care at the right time. Support Care Cancer. 2014;22(7):1981–8.CrossRefGoogle Scholar
  3. Goldstein NE, Genden E, Morrison RS. Palliative care for patients with head and neck cancer: “I would like a quick return to a normal lifestyle”. JAMA. 2008;299(15):1818–25.CrossRefGoogle Scholar
  4. Lee MS, Nelson AM, Thompson LM, Donovan KA. Supportive care needs of oral cancer survivors: prevalence and correlates. Oral Oncol. 2016;53:85–90.CrossRefGoogle Scholar
  5. PDQ Supportive and Palliative Care Editorial Board. Oral complications of chemotherapy and head/neck radiation (PDQ®): health professional version. 2016 Dec 16. In: PDQ cancer information summaries [Internet]. Bethesda: National Cancer Institute (US); 2002. Available from: Scholar
  6. Sroussi HY, Epstein JB, Bensadoun RJ, Saunders DP, Lalla RV, Migliorati CA, Heaivilin N, Zumsteg ZS. Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis. Cancer Med. 2017;6(12):2918–31.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Special Care Dentistry Unit, School of Medicine and DentistryUniversity of Santiago de CompostelaSantiago de CompostelaSpain

Personalised recommendations